Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure–Activity Relationships and Discovery Strategies To Mitigate Drug–Drug Interaction Risks

DOI Web Site 2 Citations

Suvi T. M. Orr
Sharon L. Ripp
T. Eric Ballard
Jaclyn L. Henderson
Dennis O. Scott

Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, 620 Memorial Drive, Cambridge, Massachusetts 02139, United States
R. Scott Obach
Hao Sun
Amit S. Kalgutkar

Pharmacokinetics, Dynamics and Metabolism, Pfizer Global Research and Development, 620 Memorial Drive, Cambridge, Massachusetts 02139, United States

Journal

Journal of Medicinal Chemistry

Journal of Medicinal Chemistry 55 (11), 4896-4933, 2012-03-27

American Chemical Society (ACS)

Citations (2)*help

See more

Details 詳細情報について

CRID

1361699994832259712
DOI

10.1021/jm300065h
ISSN

15204804

00222623
Web Site

https://pubs.acs.org/doi/pdf/10.1021/jm300065h
Data Source
- Crossref

Export

Report a problem

Back to top